L-Carnitine and Increased Insulin-like Growth Factor-1 Level

Doses used in studies

Time to effect

Median: 8 weeks · IQR 8 weeks–8 weeks · Range 8 weeks–8 weeks — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityReported
The abstract does not report any adverse events, side effects, or safety findings. It only reports efficacy/ biomarker outcomes (IGF-1, CK, myostatin, myogenin levels). No tolerability statement is made.
from: l-carnitine downregulate the muscle wasting effect of glucocorticoids in pemphigus patient

1 of 1 paper

l-carnitine downregulate the muscle wasting effect of glucocorticoids in pemphigus patient: A randomized double-blind placebo-controlled study.